
Top stocks to buy today: Stock recommendations for May 13, 2025
JP Morgan is underweight on Dr Reddy’s Laboratories with the target price at Rs 1,060. Analysts said the pharma major’s Jan-March revenue was in line, but EBITDA missed estimates. According to them the underweight rating is premised on weak core EBITDA margins, lacklustre growth in India, lack of visibility on niche launches in the US…